Stock NEOP NEOPROBE CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Insiders Neoprobe Corporation Nyse

Equities

NEOP

US6405181065

End-of-day quote Nyse
Other stock markets
- USD - Intraday chart for Neoprobe Corporation
Jul. 03 Navidea Biopharmaceuticals, Inc. Announces Results of Exploratory Analysis Completed on July 2, 2024 CI
Jun. 21 Navidea Biopharmaceuticals, Inc. Announces Board Resignations CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Navidea Biopharmaceuticals, Inc. Announces Board Resignations
CI
Navidea Biopharmaceuticals, Inc. Announces Resignation of Malcolm G. Witter as Director, Member of the Audit Committee and Compensation, Nominating and Governance Committee of the Board
CI
Navidea Biopharmaceuticals, Inc. Announces Executive Changes
CI
Navidea Biopharmaceuticals, Inc. Announces Board Changes
CI
Navidea Biopharmaceuticals, Inc. Announces Board Changes
CI
Navidea Biopharmaceuticals Promotes Michael Sherman Blue to Chief Medical Officer
MT
Navidea Biopharmaceuticals, Inc. Promotes Michael Sherman Blue, M.D., FACEP, to Chief Medical Officer
CI
Navidea Biopharmaceuticals, Inc. Announces Resignation of Michael Rosol as Chief Medical Officer, Effective April 10, 2023
CI
Navidea Biopharmaceuticals, Inc. Announces Executive Changes
CI
Navidea Biopharmaceuticals, Inc. Appoints Joshua Wilson to the Board of Directors
CI
Navidea Biopharmaceuticals Announces Executive Changes
CI
Navidea Biopharmaceuticals Announces Board Changes, Effective December 5, 2021
CI
Navidea Biopharmaceuticals CEO Jed Latkin Resigns
MT
Navidea Biopharmaceuticals, Inc. Announces Resignation of Jed A. Latkin, as Chief Operating Officer, Member of the Board of Directors
CI
Navidea Biopharmaceuticals, Inc. Announces Resignation of Jed A. Latkin as Chief Executive Officer
CI
Navidea Biopharmaceuticals Appoints Thomas Forest Farb-Horch and Agnieszka Winkler to the Board of Directors
CI
Navidea Biopharmaceuticals Appoints Michel Mikhail as Chief Regulatory Officer, Effective October 1, 2021
CI
Navidea Biopharmaceuticals' : Board Chair Retires, Replacement Named
MT
Navidea Biopharmaceuticals Announces Board and Committee Changes
CI
Navidea Biopharmaceuticals, Inc. Announces Board Appointments
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NAVB Stock
  4. NEOP Stock
  5. News Neoprobe Corporation
  6. Insiders